Stanford University


Showing 1-35 of 35 Results

  • Muhammad Abdelbasset Muhammad Ahmad

    Muhammad Abdelbasset Muhammad Ahmad

    Postdoctoral Scholar, Infectious Diseases

    BioPostdoctoral fellow, Department of Medicine, Stanford University (2022– Present).

    PhD, Duke-National University of Singapore (2017 – 2021).

    MSc, Faculty of Pharmacy, Cairo University (2014 – 2016).

    BSc, Faculty of Pharmacy, Cairo University (2007 – 2012).

  • Ronan Arthur

    Ronan Arthur

    Postdoctoral Scholar, Infectious Diseases

    BioRonan Arthur (PhD) is a postdoctoral scholar in the Stanford School of Medicine and in the Department of Biology. Ronan studies adaptive behavior and community trust during epidemics through mathematical modeling techniques and empirical work in Liberia. Current research includes: hospital hand hygiene in Liberia; hospital ventilation in rural Liberia; adaptive behavior during epidemics with age-structure; quantifying gene-culture co-evolution; trust of government and health system during COVID-19 in Liberia; and agent-based modeling of COVID-19 and Ebola Virus Disease.

  • Florian Bach

    Florian Bach

    Postdoctoral Scholar, Infectious Diseases

    BioI'm a molecular infection biologist by training, but shifted my focus from pathogens to hosts for my graduate research. During my PhD with Phil Spence in Edinburgh I studied both falciparum and vivax malaria using controlled human (re)infection models, collaborating closely with the groups of Simon Draper and Angela Minassian in Oxford. As a hybrid bioinformatician and experimentalist, I love systems immunology for answering complex questions about human health. For my postdoc, I study in how the human immune response to malaria evolves in infants as they become reinfected and age. I'm also interested in how such early-life immunological events, malaria and beyond, may affect vaccine responses and immune development later in life. I address this question by making use of a longitudinal study cohort of infants receiving monthly chemoprevention in Eastern Uganda, together with our collaborators at UC San Francisco and IDRC Uganda.

  • Jeffrey Bunker

    Jeffrey Bunker

    Postdoctoral Medical Fellow, Infectious Diseases
    Fellow in Graduate Medical Education

    BioJeffrey Bunker is an infectious diseases physician-scientist, immunologist, and microbiologist. He is currently a clinical fellow in infectious diseases at Stanford University; he previously completed residency training in internal medicine at Stanford University and an M.D. and Ph.D. in immunology at the University of Chicago. Bunker’s research investigates interactions between the microbiome and the immune system, including fundamental questions about how and why certain microbes generate immune responses and how this interplay influences both normal homeostasis and infectious or inflammatory diseases. His clinical interests include microbial pathogenesis, antimicrobial resistance, and the diagnosis and treatment of complex infections.

  • Jessica Grembi

    Jessica Grembi

    Postdoctoral Scholar, Infectious Diseases

    BioEnvironmental enteric dysfunction (EED) affects 50-90% of children in low-income countries and is likely an important factor in child stunting as it impedes efficient nutrient uptake in the small intestine. EED is suspected to be the result of persistent exposure to enteric pathogens, although it has not been correlated with any specific pathogen. My research explores the interplay of gut microbiota, including enteric pathogens, and the host immune system with a focus on understanding EED so we can rationally design treatments and preventive measures.

  • Abraar Karan, MD MS MPH DTM&H

    Abraar Karan, MD MS MPH DTM&H

    Postdoctoral Medical Fellow, Infectious Diseases

    BioI am an infectious disease fellow and post-doctoral researcher in the Division of Infectious Diseases and Geographic Medicine, the Luby Lab, the Center for Innovation in Global Health, the King Center on Global Development, and the Woods Institute for the Environment. I worked on the Covid19 outbreak for the Massachusetts Department of Public Health in 2020, and the Monkeypox outbreak for the Los Angeles County Department of Public Health in 2022-23. I also served on the WHO-commissioned Independent Panel on Pandemic Preparedness and Response's research team investigating early global spread of Covid19, and helped with policy-writing for the Biden-Harris campaign on reducing Covid19 in schools. I am currently the Principal Investigator of the following studies: a cluster-randomized controlled trial investigating whether air filtration and ventilation can reduce spread of Covid19 in low-income homes in the Bay Area (https://clinicaltrials.gov/ct2/show/NCT05777720); piloting a low-cost rural surveillance system for detecting spillover of zoonotic diseases in Western Kenya.

    I completed my internal medicine residency at the Brigham and Women's Hospital/Harvard Medical School in the Global Health Equity program, and have been working in global health since 2008. I co-edited the book, "Protecting the Health of the Poor" (December 2015, Bloomsbury Publishing, https://www.bloomsbury.com/us/protecting-the-health-of-the-poor-9781783605521/); and co-founded Longsleeve insect repellent, winner of the 2018 Harvard Business School New Venture Competition and finalist in the 2019 Harvard President's Challenge. Media/press coverage has included NBC, ABC, BBC, PBS, CBS, CNN, MSNBC, Fox News, Washington Post, New York Times, SF Chronicle, Bloomberg, Boston Globe, ProPublica, WSJ, TIME, Politico, CBC News, Democracy Now, NPR, ESPN, The Atlantic, The Hill, Business Insider, Vice, Mother Jones, Vox, Forbes, Slate, STAT News, MTV News, Mother Jones, Science Friday, TMZ.

    For a full list of publications, please see "Publications" tab. For full list of press/media interviews, please see "Media" link.

  • Max Lamparth

    Max Lamparth

    Postdoctoral Scholar, Infectious Diseases

    BioMax is a postdoctoral fellow at the Center for International Security and Cooperation, the Stanford Center for AI Safety, and the Stanford Existential Risks Initiative at Stanford University. I am advised by Prof. Clark Barrett, Prof. Steve Luby, and Prof. Paul Edwards.

    With his research, he wants to make AI systems more secure and safe to use. Specifically, he is focussing on how to improve the robustness and alignment of language models, how to make their inner workings more interpretable, and how to reduce the potential for misuses.

    He received his Ph.D. in August 2023 from the Physics Department at the Technical University of Munich and previously a B.Sc. and M.Sc. from the Ruprecht Karl University of Heidelberg.

  • Ruoxi Pi

    Ruoxi Pi

    Postdoctoral Scholar, Infectious Diseases

    BioI received my BS in Biological Sciences in Zhejiang University in China, where I conducted research in polyphasic taxonomy in anaerobic bacteria. I received my PhD in Yale University, where I studied the early events of retrovirus infection in animal models. Now in the Blish lab, I am investigating NK cell responses during HIV-1 infection and trying to manipulate the NK cells to target latently infected cells.

  • Izabela Mauricio Rezende

    Izabela Mauricio Rezende

    Postdoctoral Scholar, Infectious Diseases

    BioI have a B.S. in Biology, M.Sc. in Immunology and Infectious diseases, Ph.D. in Microbiology. I am currently a Postdoctoral Researcher at the Stanford University School of Medicine, working with Dr. Jason Andrews at the new Stanford Pandemic Preparedness Hub, a fellowship I was awarded at the end of 2022. As part of a pandemic preparedness, We are tytrying to understand the potential viruses at risk of pandemic spread. Using disease modeling, epidemiological, and phylogenetic analysis, we study the genomic evolution and transmission dynamics of H5N1 avian influenza A after 2020.

    I am in my third postdoctoral year at Stanford and completed the first two years with Dr. Desiree LaBeaud. I have a Ph.D. in Microbiology, with an emphasis in Virology, and a Master’s in Infectious Diseases. . My Ph.D. was conducted in Brazil, under the supervision of Dr. Betânia Drumond, and contemplated the virological and epidemiological aspects of yellow fever (YF) outbreak in Minas Gerais/BR in 2017-2018, combining laboratory, clinical, and data analysis (publications: DOI 10.1126/science.aat7115; DOI 10.1371/journal.pntd.0006538; DOI 10.1128/jcm.00254-22; DOI 10.3390/vaccines7040206; DOI 10.1186/s12985-019-1277-7). I came to Stanford University for my first postdoc with Dr. Desiree LaBeaud. For two years, I led an international NIH R01 project investigating the dynamics of the biggest YF outbreak in Brazil, including the description of a new syndrome, Late-relapsing hepatitis after yellow fever (DOI 10.3390/v12020222), and risk factors for severe YF. I was also involved in other projects regarding SARS-CoV-2 variants and disease severity in infants (DOI 10.3389/fmed.2022.896352), Rift Valley fever virus epidemiology in humans and animals in Kenya (DOI 10.1371/journal.pgph.0000505), and dengue virus evolution in Africa (ongoing Ph.D. candidate mentorship).

    During the COVID-19 pandemic, we also supported the Brazilian Ministry of Health with the SARS-CoV-2 diagnosis in human samples and also in the investigation of the SARS-CoV-2 RNA in surfaces of density public areas of Belo Horizonte. Since Nov/2018 I had been an editor in the journal Docência do Ensino Superior (RDES / GIZ / UFMG) and in Jan/2020 I became Editor-in-Chief.

  • Melissa Salm

    Melissa Salm

    Postdoctoral Scholar, Infectious Diseases

    Current Research and Scholarly InterestsGlobal health, medical anthropology, and biosecurity with a focus on the One Health approach to infectious disease epidemiology, viral discovery and risk characterization of pandemic potential pathogens, global health governance, and transdisciplinary approaches to public health innovation

  • Benjamin Singer

    Benjamin Singer

    Postdoctoral Scholar, Infectious Diseases

    BioBen Singer is a postdoctoral scholar with interests in mathematical epidemiology and global public health. Ben's research career began with an internship at the Okinawa Institute of Science and Technology, where he applied quantitative skills he had learnt studying physics at the University of Oxford to the study of nematode locomotion. Ben further pursued quantitative methods in life sciences in the Interdisciplinary Bioscience Doctoral Training Partnership at the University of Oxford, earning a DPhil (PhD equivalent) in mathematical methods for evaluating pandemic risk and control. During these studies he maintained an interest in global public health policy, interning with the UK government's Department for International Development, where he developed models of international COVID-19 vaccine distribution. Ben is now working in Nathan Lo's research group at Stanford, creating infectious disease models informing public health policy for schistosomiasis, hepatitis E, and other infections.

  • Daniel Zimmer

    Daniel Zimmer

    Postdoctoral Scholar, Infectious Diseases

    Current Research and Scholarly InterestsMy research focuses on the scientific history of anthropogenic existential risk and its impact on Western political thought. I focus in particular on the development of massed thermonuclear arsenals during the 1950s, the rise of Earth System science and attendant ecological risks during the 1980s, and the anxieties surrounding the prospect of artificial super intelligence that took hold in the 2000s.